Crossmark

Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers

Crossref DOI link: https://doi.org/10.1136/jitc-2022-004793

Published Online: 2022-09-28

Published Print: 2022-09

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Kaneko, Kensuke

Acharya, Chaitanya R https://orcid.org/0000-0001-7149-1749
Nagata, Hiroshi

Yang, Xiao

Hartman, Zachary Conrad https://orcid.org/0000-0001-6549-8207
Hobeika, Amy

Hughes, Philip F

Haystead, Timothy A J

Morse, Michael A

Lyerly, Herbert Kim https://orcid.org/0000-0002-0063-4770
Osada, Takuya https://orcid.org/0000-0003-1424-5001
Funding

Funding for this research was provided by:

U.S. Department of Defense (BC111085 / W81XWH-12-1-0447)
License Information

License valid from 2022-09-28

Document is current

Any future updates will be listed below